Dr. Martin Fehr
Medizinische Onkologie und Hämatologie · Dept. I
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).
Novak U, Fehr M, Schär S, Dreyling M, Schmidt C, Derenzini E, Zander T, Hess G, Mey U, Ferrero S, Mach N, Boccomini C, Böttcher S, Voegeli M, Cairoli A, Ivanova V, Menter T, Dirnhofer S, Scheibe B, Gadient S, Eckhardt K, Zucca E, Driessen C, Renner C. Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine 2023; 64:102221.
Sep 22, 2023Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).
Sep 22, 2023EClinicalMedicine 2023; 64:102221
Novak Urban, Fehr Martin, Schär Sämi, Dreyling Martin, Schmidt Christian, Derenzini Enrico, Zander Thilo, Hess Georg, Mey Ulrich J M, Ferrero Simone, Mach Nicolas, Boccomini Carola, Böttcher Sebastian, Voegeli Michèle, Cairoli Anne, Ivanova Vanesa-Sindi, Menter Thomas, Dirnhofer Stefan, Scheibe Bernhard, Gadient Sandra, Eckhardt Katrin, Zucca Emanuele, Driessen Christoph, Renner Christoph
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Hilberink J, van Zeventer I, Chitu D, Pabst T, Klein S, Stussi G, Griskevicius L, Valk P, Cloos J, van de Loosdrecht A, Breems D, van Lammeren-Venema D, Boersma R, Jongen-Lavrencic M, Fehr M, Hoogendoorn M, Manz M, Söhne M, van Marwijk Kooy R, Deeren D, van der Poel M, Legdeur M, Tick L, Chalandon Y, Ammatuna E, Blum S, Löwenberg B, Ossenkoppele G, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Huls G. Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood Cancer J 2023; 13:93.
Jun 19, 2023Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Jun 19, 2023Blood Cancer J 2023; 13:93
Hilberink Jacobien R, van Zeventer Isabelle A, Chitu Dana A, Pabst Thomas, Klein Saskia K, Stussi Georg, Griskevicius Laimonas, Valk Peter J M, Cloos Jacqueline, van de Loosdrecht Arjan A, Breems Dimitri A, van Lammeren-Venema Daniëlle, Boersma Rinske, Jongen-Lavrencic Mojca, Fehr Martin, Hoogendoorn Mels, Manz Markus G, Söhne Maaike, van Marwijk Kooy Rien, Deeren Dries, van der Poel Marjolein W M, Legdeur Marie-Cecile J C, Tick Lidwine W, Chalandon Yves, Ammatuna Emanuele, Blum Sabine, Löwenberg Bob, Ossenkoppele Gert J, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Huls Gerwin
Severe Pancytopenia induced by Metamizole
Spasojevic N, Tobler M, Fehr M, Henz S (2023). Severe Pancytopenia induced by Metamizole.
May 10, 2023Severe Pancytopenia induced by Metamizole
May 10, 2023SGAIM Frühjahrskonferenz
Spasojevic Natalija, Tobler Micaela, Fehr Martin, Henz Samuel
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Brune M, Cogliatti S, Ossenkoppele G, Löwenberg B, Rudolf C, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A, Fehr M, Grobholz R, Stussi G, Lundberg P, Vela V, Heim D, Manz M, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol 2021; 100:1169-1179.
Mar 2, 2021Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Mar 2, 2021Ann Hematol 2021; 100:1169-1179
Brune Magdalena M, Cogliatti Sergio B., Ossenkoppele Gert J, Löwenberg Bob, Rudolf Christina Biaggi, Li Qiyu, Passweg Jakob, Mazzuchelli Luca, Medinger Michael, Tzankov Alexandar, Fehr Martin, Grobholz Rainer, Stussi Georg, Lundberg Pontus, Vela Visar, Heim Dominik, Manz Markus G, Haralambieva Eugenia, Pabst Thomas, Banz Yara, Bargetzi Mario, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
Moccia A, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Mey U, Lang N, Aeppli S, Güsewell S, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr M, Fischer N, Ghilardi G, Krasniqi F, Hitz F. Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematol Oncol 2020; 39:196-204.
Dec 23, 2020Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
Dec 23, 2020Hematol Oncol 2020; 39:196-204
Moccia A A, Mingrone W, Novak U, Pfleger C, Richter P, Rütti M, Schmidt A, Stenner F, Voegeli M, Zander T, Zucca E, Mey U, Lang N, Aeppli Stefanie, Güsewell Sabine, Bargetzi M, Caspar C, Brülisauer D, Ebnöther M, Fehr Martin, Fischer N, Ghilardi G, Krasniqi F, Hitz Felicitas
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
Araf S, Fitzgibbon J, Okosun J, Johnson P, Davies A, Rimsza L, Scott D, Graham T, Barrington S, Forrer F, Kumar E, Cogliatti S, Wang J, Bewicke-Copley F, Korfi K, Fehr M. Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma. Haematologica 2020; 105:318-321.
Apr 9, 2020Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
Apr 9, 2020Haematologica 2020; 105:318-321
Araf Shamzah, Fitzgibbon Jude, Okosun Jessica, Johnson Peter, Davies Andrew, Rimsza Lisa M, Scott David W, Graham Trevor A, Barrington Sally F, Forrer Flavio, Kumar Emil, Cogliatti Sergio B., Wang Jun, Bewicke-Copley Findlay, Korfi Koorosh, Fehr Martin
Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Pirker I, Rubbert-Roth A, von Kempis J, Fehr M, Neumann T. Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy. Clin Exp Rheumatol 2020
Jan 28, 2020Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
Jan 28, 2020Clin Exp Rheumatol 2020
Pirker Ian, Rubbert-Roth Andrea, von Kempis Johannes, Fehr Martin, Neumann Thomas
Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature
Fehr M, Cathomas G, Graber A, Markert E, Gaus E, Boggian K. Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature. Med Mycol Case Rep 2019; 27:14-16.
Dec 3, 2019Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature
Dec 3, 2019Med Mycol Case Rep 2019; 27:14-16
Fehr Martin, Cathomas Gieri, Graber Anne, Markert Eva, Gaus Elisabeth, Boggian Katia
Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
Fehr M, Maranta A, Reichegger H, Gillessen Sommer S, Cathomas R. Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I. ESMO Open 2018; 3:e000320.
Mar 8, 2018Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
Mar 8, 2018ESMO Open 2018; 3:e000320
Fehr Martin, Maranta Angela Fischer, Reichegger Hermann, Gillessen Sommer Silke, Cathomas Richard
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Fehr M, Müller J, Knitel M, Fornaro J, Horber D, Koeberle D, Cerny T, Gueller U. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clin Colorectal Cancer 2017
Mar 21, 2017Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Mar 21, 2017Clin Colorectal Cancer 2017
Fehr Martin, Müller Joachim, Knitel Meinhard, Fornaro Jürgen, Horber Daniel, Koeberle Dieter, Cerny Thomas, Gueller Ulrich
Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011
Feller A, Clough-Gorr K, Arndt V, Steiner A, Mousavi M, Frick H, Bouchardy C, Bordoni A, Fehr M, The Nicer Working Group. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011. Swiss Med Wkly 2015; 145:w14245.
Dec 10, 2015Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011
Dec 10, 2015Swiss Med Wkly 2015; 145:w14245
Feller Anita, Clough-Gorr Kerri M, Arndt Volker, Steiner Annik, Mousavi Mohsen, Frick Harald, Bouchardy Christine, Bordoni Andrea, Fehr Martin, The Nicer Working Group
Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy
Zeuge U, Fehr M, Meyenberger C, Sulz M. Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy. Case Rep Gastroenterol 2014; 8:358-63.
Nov 13, 2014Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy
Nov 13, 2014Case Rep Gastroenterol 2014; 8:358-63
Zeuge Ulf, Fehr Martin, Meyenberger Christa, Sulz Michael
Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy
Zeuge U, Fehr M, Meyenberger C, Sulz M. Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy. Case Reports in Gastroentrerology 2014; 8:358-363.
Nov 1, 2014Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy
Nov 1, 2014Case Reports in Gastroentrerology 2014; 8:358-363
Zeuge Ulf, Fehr Martin, Meyenberger Christa, Sulz Michael
Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea
Fehr M, Geldart T, Klingbiel D, Cathomas R. Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea. Eur J Cancer 2014; 50:2176-7.
Jun 7, 2014Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea
Jun 7, 2014Eur J Cancer 2014; 50:2176-7
Fehr Martin, Geldart Tom, Klingbiel Dirk, Cathomas Richard
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort
Cathomas R, von Moos R, Nagaraj N, Simmonds P, Wheater M, Ellis S, Mead G, Geldart T, Klingbiel D, Fehr M. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort. Ann Oncol 2014; 25:1591-7.
Mar 25, 2014Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort
Mar 25, 2014Ann Oncol 2014; 25:1591-7
Cathomas R, von Moos R, Nagaraj N, Simmonds P, Wheater M, Ellis S, Mead G M, Geldart T R, Klingbiel D, Fehr Martin
Multidisciplinary care in patients with prostate cancer: room for improvement
Strebel R, Winterhalder R, Morant R, Pless M, Huber U, Fehr M, Gillessen Sommer S, Schmid H, Sulser T, Cathomas R. Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer 2013; 21:2327-33.
Mar 26, 2013Multidisciplinary care in patients with prostate cancer: room for improvement
Mar 26, 2013Support Care Cancer 2013; 21:2327-33
Strebel Räto T, Winterhalder Ralph, Morant Rudolf, Pless Miklos, Huber Urs, Fehr Martin, Gillessen Sommer Silke, Schmid Hans-Peter, Sulser Tullio, Cathomas Richard
Multidisciplinary care in patients with prostate cancer: room for improvement
Strebel R, Winterhalder R, Morant R, Pless M, U H, Fehr M, Gillessen S, Schmid H, Sulser T, Cathomas R. Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer 2013; 21:2327-33.
Jan 1, 2013Multidisciplinary care in patients with prostate cancer: room for improvement
Jan 1, 2013Support Care Cancer 2013; 21:2327-33
Strebel RT, Winterhalder R, Morant R, Pless M, U Huber, Fehr Martin, Gillessen S, Schmid Hans-Peter, Sulser T, Cathomas R
Primary manifestation of small lymphocytic lymphoma in the prostate
Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen Sommer S, Cathomas R. Primary manifestation of small lymphocytic lymphoma in the prostate. Onkologie 2009; 32:586-8.
Oct 1, 2009Primary manifestation of small lymphocytic lymphoma in the prostate
Oct 1, 2009Onkologie 2009; 32:586-8
Fehr Martin, Templeton Arnoud, Cogliatti Sergio B., Aebersold Franziska, Egli Fritz, Gillessen Sommer Silke, Cathomas Richard